New COVID-19 cases in U.S. nursing homes have fallen to their lowest number since the Centers for Medicare & Medicaid Services (CMS) started keeping track…
Read More
With Supreme Court in mind, states aim to curb abortion rights
This is a Kaiser Health News story. When Rep. Lola Sheldon-Galloway introduced a bill in the Montana House two years ago that would have prohibited…
Read More
Pfizer and AZ COVID jabs ‘highly effective’ in elderly: UK study
The Pfizer and Oxford-AstraZeneca vaccines have been “highly effective” in reducing coronavirus infections and severe illness among elderly people in Britain, with a more than…
Read More
SARS-CoV-2 mutations in competition
Prior to the emergence of new mutants of the coronavirus, such as the British variant B.1.1.7, the SARS-CoV-2 variant named D614G had already mutated from…
Read More
Calfee named division director in orthopedic surgery
Ryan P. Calfee, MD, an associate professor of orthopedic surgery and medical director of the Washington University and Barnes-Jewish Hospital Orthopedic Center, has been named…
Read More
Transplant patients may not need steroid treatment in the long run
Long-term use of a medication used to treat kidney transplant patients may not be necessary in individuals with low-to-moderate risk of organ rejection, according to…
Read More
Drug executives: Big jump in vaccine supply is coming soon
COVID-19 vaccine makers told Congress on Tuesday to expect a big jump in the delivery of doses over the coming month, and the companies insist…
Read More
Waitlist policies may contribute to racial disparities in kidney transplant access
Despite efforts to address them, racial disparities in access to kidney transplantation persist in the United States. New research published in an upcoming issue of…
Read More
COVID’s rough road in US began with some barred from wearing masks
As the United States nears the grim milestone of half a million lives lost to COVID-19, it seems almost impossible to believe that an American…
Read More
Genetics may play role in determining immunity to COVID-19
Neutralizing antibodies develop within two weeks of a SARS-CoV-2 infection, but their durability and intensity can vary by individual, prompting concerns about the prospects of…
Read More